Walgreens Boots Alliance Q2 2025: gross sales up 4.1 p.c however EPS plummets

THE WHAT? Walgreens Boots Alliance has introduced its outcomes for the second quarter of fiscal 2025. The drug retailer conglomerate stated that gross sales elevated 4.1 p.c year-on-year to US$38.6 billion and loss per share narrowed to US$3.30 in comparison with US$6.85 within the year-ago quarter.

THE DETAILS Nevertheless, adjusted EPS was US$0.63 in comparison with US$1.20 in the identical interval final 12 months, which WBA attributed to the prior 12 months adjusted efficient tax profit, decrease retail gross sales and prior-year sale leaseback positive aspects.

The corporate is withdrawing fiscal 2025 steering in gentle of the very fact it’s to be acquired by entities affiliated with Sycamore Companions.

THE WHY? Chief Govt Officer Tim Wentworth, reveals, “Second quarter outcomes mirror disciplined value administration and enchancment in US Healthcare, which have been partially offset by weaker front-end leads to US Retail Pharmacy, whereas important authorized settlements resulted in continued destructive free money move. We stay within the early levels of our turnaround plan, and proceed to count on that significant worth creation will take time, enhanced focus and balancing future money wants with vital investments to navigate a altering pharmacy and retail panorama.”